{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:49:11Z","timestamp":1791726551522,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T00:00:00Z","timestamp":1250640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/ejhg.2009.143","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T06:21:30Z","timestamp":1250662890000},"page":"194-199","source":"Crossref","is-referenced-by-count":37,"title":["Gene silencing of EXTL2 and EXTL3 as a substrate deprivation therapy for heparan sulphate storing mucopolysaccharidoses"],"prefix":"10.1038","volume":"18","author":[{"given":"Xenia","family":"Kaidonis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Chin","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainslie Derrick","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleesa","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Anson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Byers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,19]]},"reference":[{"key":"BFejhg2009143_CR1","first-page":"3421","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J : The mucopolysaccharidoses; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease. 8th edn. USA: McGraw-Hill, 2001, vol 3, pp 3421\u20133452."},{"key":"BFejhg2009143_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"P Harmatz","year":"2006","unstructured":"Harmatz P, Giugliani R, Schwartz I et al: Enzyme replacement therapy for mucopolysaccharidosis type VI: a phase 3, randomized, double blind, placebo controlled multinational study of recombinant N-acetylgalactosamine-4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J Pediatr 2006; 148: 533\u2013539.","journal-title":"J Pediatr"},{"key":"BFejhg2009143_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","volume":"90","author":"J Muenzer","year":"2007","unstructured":"Muenzer J, Gucsavas-Calikoglu M, McCandless SE, Schuetz TJ, Kimura A : A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Mol Genet Metab 2007; 90: 329\u2013337.","journal-title":"Mol Genet Metab"},{"key":"BFejhg2009143_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","volume":"90","author":"M Sifuentes","year":"2007","unstructured":"Sifuentes M, Doroshow R, Hoft R et al: A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab 2007; 90: 171\u2013180.","journal-title":"Mol Genet Metab"},{"key":"BFejhg2009143_CR5","doi-asserted-by":"publisher","first-page":"14777","DOI":"10.1073\/pnas.0506892102","volume":"102","author":"C Vogler","year":"2005","unstructured":"Vogler C, Levy B, Grubb JH et al: Overcoming the blood\u2013brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 2005; 102: 14777\u201314782.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2009143_CR6","first-page":"565","volume":"28","author":"J Inokuchi","year":"1987","unstructured":"Inokuchi J, Radin NS : Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol inhibitor of murine glucocerebroside synthase. J Lipid Chem 1987; 28: 565\u2013571.","journal-title":"J Lipid Chem"},{"key":"BFejhg2009143_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1023\/A:1025902113005","volume":"26","author":"TM Cox","year":"2003","unstructured":"Cox TM, Aerts JM, Andria G et al: The role of the imino sugar N-butyldeoxynorjirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. J Inherit Metab Dis 2003; 26: 513\u2013526.","journal-title":"J Inherit Metab Dis"},{"key":"BFejhg2009143_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1098\/rstb.2003.1271","volume":"358","author":"C Moyses","year":"2003","unstructured":"Moyses C : Substrate reduction therapy: clinical evaluation in type I Gaucher disease. Phil Trans R Soc Lond B Biol Sci 2003; 358: 955\u2013960.","journal-title":"Phil Trans R Soc Lond B Biol Sci"},{"key":"BFejhg2009143_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1098\/rstb.2003.1272","volume":"358","author":"A Zimran","year":"2003","unstructured":"Zimran A, Elstein D : Gaucher disease and the clinical experience with substrate reduction therapy. Phil Trans R Soc Lond B Biol Sci 2003; 358: 961\u2013966.","journal-title":"Phil Trans R Soc Lond B Biol Sci"},{"key":"BFejhg2009143_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0008-6215(00)00049-5","volume":"30","author":"A Berkin","year":"2000","unstructured":"Berkin A, Szarek WA, Kisilevsky R : Synthesis of 4-deoxy-4-fluro analogues of 2-acetamido-2-deoxy-D-glucose and 2- acetamido-2-deoxy-D-galactose and their effects on cellular glycosaminoglycan biosynthesis. Carbohydr Res 2000; 30: 250\u2013263.","journal-title":"Carbohydr Res"},{"key":"BFejhg2009143_CR11","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/sj.ejhg.5201623","volume":"14","author":"E Piotrowska","year":"2006","unstructured":"Piotrowska E, Jak\u00f3bkiewicz-Banecka J, Bara\u0144ska S et al: Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet 2006; 14: 846\u2013852.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2009143_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1203\/01.pdr.0000233037.00707.da","volume":"60","author":"AL Roberts","year":"2006","unstructured":"Roberts AL, Thomas BJ, Wilkinson AS, Fletcher JM, Byers S : Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccaridosis type IIIA. Pediatr Res 2006; 60: 309\u2013314.","journal-title":"Pediatr Res"},{"key":"BFejhg2009143_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.curtheres.2008.04.002","volume":"69","author":"E Piotrowska","year":"2008","unstructured":"Piotrowska E, Jak\u00f3bkiewicz-Banecka J, ki-Szyma\u0144ska A et al: Genistein-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: an open-label, pilot study in 10 pediatric patients. Curr Ther Res Clin Exp 2008; 69: 166\u2013179.","journal-title":"Curr Ther Res Clin Exp"},{"key":"BFejhg2009143_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ymgme.2007.06.016","volume":"92","author":"AL Roberts","year":"2007","unstructured":"Roberts AL, Rees MH, Klebe S, Fletcher JM, Byers S : Improvement of behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA. Mol Genet Metab 2007; 92: 115\u2013121.","journal-title":"Mol Genet Metab"},{"key":"BFejhg2009143_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/15216540214928","volume":"54","author":"K Sugahara","year":"2002","unstructured":"Sugahara K, Kitagawa H : Heparin and heparan sulphate biosynthesis. IUBMB Life 2002; 54: 163\u2013175.","journal-title":"IUBMB Life"},{"key":"BFejhg2009143_CR16","doi-asserted-by":"publisher","first-page":"13933","DOI":"10.1074\/jbc.274.20.13933","volume":"274","author":"H Kitagawa","year":"1999","unstructured":"Kitagawa H, Shimakawa H, Sugahara K : The tumor suppressor EXT-like gene EXTL2 encodes an \u03b11,4-N-acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region. J Biol Chem 1999; 274: 13933\u201313937.","journal-title":"J Biol Chem"},{"key":"BFejhg2009143_CR17","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1073\/pnas.131188498","volume":"98","author":"BT Kim","year":"2001","unstructured":"Kim BT, Kitagawa H, Tamura J et al: Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode \u03b11,4-N-acetylglucosaminyltransferases that likely are involved in heparan sulphate\/ heparin biosynthesis. Proc Natl Acad Sci USA 2001; 98: 7176\u20137181.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2009143_CR18","doi-asserted-by":"publisher","first-page":"26265","DOI":"10.1074\/jbc.273.41.26265","volume":"273","author":"T Lind","year":"1998","unstructured":"Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K : The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulphate. J Biol Chem 1998; 273: 26265\u201326268.","journal-title":"J Biol Chem"},{"key":"BFejhg2009143_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/JCI200113530","volume":"108","author":"JD Esko","year":"2001","unstructured":"Esko JD, Lindahl U : Molecular diversity of heparan sulphate. J Clin Invest 2001; 108: 169\u2013173.","journal-title":"J Clin Invest"},{"key":"BFejhg2009143_CR20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1096\/fasebj.6.3.1740236","volume":"6","author":"TE Hardingham","year":"1992","unstructured":"Hardingham TE, Fosang AJ : Proteoglycans: many forms and many functions. FASEB J 1992; 6: 861\u2013870.","journal-title":"FASEB J"},{"key":"BFejhg2009143_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD : Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394Ct method. Methods 2001; 25: 402\u2013408.","journal-title":"Methods"},{"key":"BFejhg2009143_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM : A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248\u2013254.","journal-title":"Anal Biochem"},{"key":"BFejhg2009143_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-0556-5-1","volume":"5","author":"DS Anson","year":"2007","unstructured":"Anson DS, McIntyre C, Thomas B et al: Lentiviral-mediated gene therapy for mucopolysaccharidosis type IIIA. Genet Vaccines Ther 2007; 5: 1\u20138.","journal-title":"Genet Vaccines Ther"},{"key":"BFejhg2009143_CR24","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/jgm.803","volume":"7","author":"R Koldej","year":"2005","unstructured":"Koldej R, Cmielewski P, Stocker A, Parsons DW, Anson DS : Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production. J Gene Med 2005; 7: 1390\u20131399.","journal-title":"J Gene Med"},{"key":"BFejhg2009143_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1017\/S1355838202024032","volume":"8","author":"MT McMannus","year":"2002","unstructured":"McMannus MT, Petersen CP, Haines BB, Chen J, Sharp PA : Gene silencing using micro-RNA designed hairpins. RNA 2002; 8: 842\u2013850.","journal-title":"RNA"},{"key":"BFejhg2009143_CR26","doi-asserted-by":"publisher","first-page":"11902","DOI":"10.1074\/jbc.273.19.11902","volume":"273","author":"M Kusche-Gullberg","year":"1998","unstructured":"Kusche-Gullberg M, Eriksson I, Pikas DS, Kjell\u00e9n L : Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase\/N-sulfotransferase genes. J Biol Chem 1998; 273: 11902\u201311907.","journal-title":"J Biol Chem"},{"key":"BFejhg2009143_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0167-4781(98)00089-X","volume":"1399","author":"M Fukuta","year":"1998","unstructured":"Fukuta M, Kobayashi Y, Uchimura K, Kimata K, Habuchi O : Molecular cloning and expression of human chondroitin 6-sulfotransferase. Biochim Biophys Acta 1998; 1399: 57\u201361.","journal-title":"Biochim Biophys Acta"},{"key":"BFejhg2009143_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/glycob\/6.1.51","volume":"6","author":"O Habuchi","year":"1996","unstructured":"Habuchi O, Hirahara Y, Uchimura K, Fukuta M : Enzymatic sulfation of galactose residue of keratan sulfate by chondroitin 6-sulfotransferase. Glycobiology 1996; 6: 51\u201357.","journal-title":"Glycobiology"},{"key":"BFejhg2009143_CR29","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.1074\/jbc.273.15.9208","volume":"273","author":"H Habuchi","year":"1998","unstructured":"Habuchi H, Kobayashi M, Kimata K : Molecular characterisation and expression of heparan-sulfate 6-sulfotransferase: complete cDNA cloning in human and partial cloning in Chinese hamster ovary cells. J Biol Chem 1998; 273: 9208\u20139213.","journal-title":"J Biol Chem"},{"key":"BFejhg2009143_CR30","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.1074\/jbc.271.13.7645","volume":"271","author":"M Kobayashi","year":"1996","unstructured":"Kobayashi M, Habuchi H, Habuchi O, Saito M, Kimata K : Purification and characterisation of heparan sulfate 2-sulfotransferase from cultured Chinese hamster ovary cells. J Biol Chem 1996; 271: 7645\u20137653.","journal-title":"J Biol Chem"},{"key":"BFejhg2009143_CR31","doi-asserted-by":"publisher","first-page":"10474","DOI":"10.1074\/jbc.274.15.10474","volume":"274","author":"M Kobayashi","year":"1999","unstructured":"Kobayashi M, Sugumaran G, Liu J, Shworak NW, Silbert JE, Rosenberg RD : Molecular cloning and characterisation of a human uronyl 2-sulfotransferase that sulfates iduronyl and glucuronyl residues in dermatan\/chondroitin sulfate. J Biol Chem 1999; 274: 10474\u201310480.","journal-title":"J Biol Chem"},{"key":"BFejhg2009143_CR32","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1074\/jbc.274.4.2456","volume":"274","author":"S Yamauchi","year":"1999","unstructured":"Yamauchi S, Hirahara Y, Usui H et al: Purification and characterisation of chondroitin 4-sulfotransferase from the culture medium of a rat chondrosarcoma cell line. J Biol Chem 1999; 274: 2456\u20132463.","journal-title":"J Biol Chem"},{"key":"BFejhg2009143_CR33","unstructured":"Dziedzic D, Wegrzyn G, Jakobkiewicz-Banecka : Impairment of glycosaminoglycan synthesis in MPS IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease. Eur J Human Genet, In Press."},{"key":"BFejhg2009143_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nm828","volume":"9","author":"E Song","year":"2003","unstructured":"Song E, Lee SK, Wang J et al: RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003; 9: 347\u2013351.","journal-title":"Nat Med"},{"key":"BFejhg2009143_CR35","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.nbd.2006.04.019","volume":"23","author":"X Xia","year":"2006","unstructured":"Xia X, Zhou H, Huang Y, Xu Z : Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutics in vivo. Neurobiol Dis 2006; 23: 578\u2013586.","journal-title":"Neurobiol Dis"},{"key":"BFejhg2009143_CR36","doi-asserted-by":"publisher","first-page":"10238","DOI":"10.1073\/pnas.0802759105","volume":"105","author":"MD White","year":"2008","unstructured":"White MD, Farmer M, Mirabile I, Brandner S, Collinge J, Mallucci GR : Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci USA 2008; 105: 10238\u201310243.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2009143_CR37","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper SQ, Staber PD, He X et al: RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc Natl Acad Sci USA 2005; 102: 5820\u20135825.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:57:48Z","timestamp":1684414668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2009143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,19]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BFejhg2009143"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2009.143","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,19]]}}}